FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Caraco Pharmaceutical Laboratories Venlafaxine Hydrochloride Extended-Release Recall

Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-count bot…

Caraco Pharmaceutical Laboratories, Ltd. · Detroit, MI

Risk level
Class II
Reported by FDA
May 7, 2014
Recall ID
D-1283-2014
Check your lot numberHow we source this data

Summary

Caraco Pharmaceutical Laboratories recalled Venlafaxine Hydrochloride Extended-Release starting Mar 20, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1283-2014 on May 7, 2014. Reason: Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.

Product description

Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-count bottles (NDC 41616-758-83, UPC 3 41616 75883 2); and b) 90-count bottles (NDC 41616-758-81, UPC 3 41616 75881 8), Rx only, Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India.

Lot numbers, UPCs & expiration codes

Lot #: a) JKL3354A, Exp 04/14; JKL5444A, Exp 08/14; JKL5457B, JKL5445A, Exp 09/14; JKL5840A, Exp 10/14; JKL6588A, Exp 11/14; b) JKL3354B, Exp 04/14; JKL5444B, Exp 08/14; JKL5457C, JKL5445B, Exp 09/14; JKL5840B, Exp 10/14.

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1283-2014
Classification
Class II
Status
Terminated
Recall initiated
Mar 20, 2014
FDA report date
May 7, 2014
Quantity
160,105 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Caraco Pharmaceutical Laboratories, Ltd.

Original FDA data

Every field from FDA enforcement report D-1283-2014, exactly as published.

Show all FDA fields
City
Detroit
State
MI
Status
Terminated
Country
United States
Event ID
67784
Address
1150 Elijah McCoy Dr
Code information
Lot #: a) JKL3354A, Exp 04/14; JKL5444A, Exp 08/14; JKL5457B, JKL5445A, Exp 09/14; JKL5840A, Exp 10/14; JKL6588A, Exp 11/14; b) JKL3354B, Exp 04/14; JKL5444B, Exp 08/14; JKL5457C, JKL5445B, Exp 09/14; JKL5840B, Exp 10/14.
Postal code
48202-3344
Report date
May 7, 2014
Product type
Drugs
Recall number
D-1283-2014
Classification
Class II
Recalling firm
Caraco Pharmaceutical Laboratories, Ltd.
Product quantity
160,105 bottles
Termination date
Feb 24, 2015
Reason for recall
Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-count bottles (NDC 41616-758-83, UPC 3 41616 75883 2); and b) 90-count bottles (NDC 41616-758-81, UPC 3 41616 75881 8), Rx only, Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 20, 2014
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 29, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1283-2014, published May 7, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls